GTBP

GT Biopharma (GTBP)

GT Biopharma Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GTBP

1 2 3 4 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
17/06/2024	22h26	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
13/06/2024	22h14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
07/06/2024	23h25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
24/05/2024	02h31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
23/05/2024	12h04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GTBP	GT Biopharma Inc
23/05/2024	12h02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
15/05/2024	23h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
14/02/2024	20h46	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
01/02/2024	18h15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
21/12/2023	21h30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
04/12/2023	23h00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
06/11/2023	23h25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
06/11/2023	23h23	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
06/11/2023	23h21	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:GTBP	GT Biopharma Inc
01/11/2023	14h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
27/10/2023	23h23	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:GTBP	GT Biopharma Inc
19/09/2023	17h56	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GTBP	GT Biopharma Inc
22/08/2023	22h55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
16/08/2023	01h29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
16/08/2023	01h26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
07/08/2023	15h30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
05/07/2023	15h00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	23h30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	23h29	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	01h15	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GTBP	GT Biopharma Inc
04/05/2023	15h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
12/04/2023	01h00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GTBP	GT Biopharma Inc
30/03/2023	23h02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GTBP	GT Biopharma Inc
14/02/2023	18h55	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GTBP	GT Biopharma Inc
04/01/2023	12h23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc